Rejuvenate Biomed Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $18.3M

  • Investors
  • 6

Rejuvenate Biomed General Information

Description

Operator of a biomedical company intended to develop safe and synergistic combination drugs to delay the onset of age-related diseases. The company uses large datasets and applies network biology to identify drug combinations that can restore complex biological systems, enabling medical researchers to balance core biological processes associated with age-related functional decline.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Agoralaan A-bis
  • 3590 Diepenbeek
  • Belgium
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Agoralaan A-bis
  • 3590 Diepenbeek
  • Belgium

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rejuvenate Biomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series B) 07-Aug-2025 $18.3M Completed Generating Revenue
5. Merger/Acquisition 12-Oct-2021 Cancelled Generating Revenue
4. Early Stage VC (Series A) 02-Mar-2021 Completed Generating Revenue
3. Grant 10-Aug-2018 Completed Startup
2. Accelerator/Incubator 01-Mar-2018 $528K Completed Startup
1. Seed Round 01-Nov-2017 $528K $528K Completed Startup
To view Rejuvenate Biomed’s complete valuation and funding history, request access »

Rejuvenate Biomed Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred Class C2
Preferred Class C1
Series B
A2 Shares 180,389 $18.21 $18.21 1x $18.21 14.39%
A1 Shares 46,155 $11.34 $11.34 1x $11.34 0%
To view Rejuvenate Biomed’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Rejuvenate Biomed Patents

Rejuvenate Biomed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023376163-A1 Galantamine minitablets Pending 07-Nov-2022
EP-4615421-A1 Galantamine minitablets Active 07-Nov-2022
EP-4615421-B1 Galantamine minitablets Active 07-Nov-2022
EP-4615421-C0 Galantamine minitablets Active 07-Nov-2022
ES-3082869-T3 Galantamine minitablets Active 07-Nov-2022 A61K9/2095
To view Rejuvenate Biomed’s complete patent history, request access »

Rejuvenate Biomed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rejuvenate Biomed Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Centenara Labs Venture Capital Minority
Dyfan Investment Impact Investing Minority
LRM Venture Capital Minority
Vesalius Biocapital Partners Venture Capital Minority
VLAIO Limited Partner Minority
You’re viewing 5 of 6 investors. Get the full list »

Rejuvenate Biomed FAQs

  • When was Rejuvenate Biomed founded?

    Rejuvenate Biomed was founded in 2017.

  • Where is Rejuvenate Biomed headquartered?

    Rejuvenate Biomed is headquartered in Diepenbeek, Belgium.

  • What is the size of Rejuvenate Biomed?

    Rejuvenate Biomed has 15 total employees.

  • What industry is Rejuvenate Biomed in?

    Rejuvenate Biomed’s primary industry is Drug Discovery.

  • Is Rejuvenate Biomed a private or public company?

    Rejuvenate Biomed is a Private company.

  • What is the current valuation of Rejuvenate Biomed?

    The current valuation of Rejuvenate Biomed is .

  • What is Rejuvenate Biomed’s current revenue?

    The current revenue for Rejuvenate Biomed is .

  • How much funding has Rejuvenate Biomed raised over time?

    Rejuvenate Biomed has raised $24M.

  • Who are Rejuvenate Biomed’s investors?

    Centenara Labs, Dyfan Investment, LRM, Vesalius Biocapital Partners, and VLAIO are 5 of 6 investors who have invested in Rejuvenate Biomed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process